Share This Author
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- C. Polman, S. Reingold, J. Wolinsky
- Medicine, PsychologyAnnals of neurology
- 1 February 2011
TLDR
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- A. Thompson, B. Banwell, Jeffrey A. Cohen
- Medicine, PsychologyThe Lancet Neurology
- 21 December 2017
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
- Jeffrey A. Cohen, F. Barkhof, L. Kappos
- Medicine, PsychologyThe New England journal of medicine
- 5 March 2010
TLDR
Defining the clinical course of multiple sclerosis
- F. Lublin, S. Reingold, C. Polman
- Medicine, PsychologyNeurology
- 15 July 2014
TLDR
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- X. Montalban, S. Hauser, J. Wolinsky
- Medicine, PsychologyThe New England journal of medicine
- 19 January 2017
TLDR
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- S. Sawcer, G. Hellenthal, A. Compston
- Biology, MedicineNature
- 1 August 2011
TLDR
Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis
TLDR
Multiple Sclerosis Severity Score
- R. Roxburgh, S. Seaman, D. Compston
- Medicine, PsychologyNeurology
- 12 April 2005
TLDR
Differential diagnosis of suspected multiple sclerosis: a consensus approach
- D. Miller, B. Weinshenker, C. Polman
- Medicine, PsychologyMultiple sclerosis
- 1 November 2008
Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings. A systematic process for exclusion of…
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
- David J. Miller, F. Barkhof, X. Montalban, A. Thompson, M. Filippi
- Medicine, PsychologyThe Lancet Neurology
- 1 May 2005
...
...